AR019859A1 - Derivados diaza-espiro[3,5]nonano, un procedimiento para su preparacion, composiciones farmaceuticas que los comprenden y el uso de los mismos para la preparacion de un medicamento - Google Patents

Derivados diaza-espiro[3,5]nonano, un procedimiento para su preparacion, composiciones farmaceuticas que los comprenden y el uso de los mismos para la preparacion de un medicamento

Info

Publication number
AR019859A1
AR019859A1 ARP990102763A ARP990102763A AR019859A1 AR 019859 A1 AR019859 A1 AR 019859A1 AR P990102763 A ARP990102763 A AR P990102763A AR P990102763 A ARP990102763 A AR P990102763A AR 019859 A1 AR019859 A1 AR 019859A1
Authority
AR
Argentina
Prior art keywords
preparation
lower alkyl
naphthalen
hydrogen
diaza
Prior art date
Application number
ARP990102763A
Other languages
English (en)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of AR019859A1 publication Critical patent/AR019859A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Abstract

Derivados diaza-espiro[3,5]nonano, que comprenden compuestos de la formula general (1) en donde R1 es cicloalquilo de 6 a 12 átomos de carbono,opcionalmente sustituido con alquilo inferior o C(O)alquilo inferior; indan-1-ilo o indan-2-ilo,opcionalme nte sustituido con alquilo inferior; acenaften -1-ilo; biciclo [3.3.1]non-9-ilo; octahidro-inden-2-ilo; 2,3-dihidro-1H-fenalen-1-ilo; 2,3,3a,4,5,6-hexahidro-1H-fenalen-1-ilo; decahidro-azulen-2-ilo; biciclo[6.2.0.]dec-9-ilo; decahidro-naftalen-1-ilo, decahidro-naftalen-2-ilo; tetrahidro-naftalen-1-ilo; tetrahidro-naftalen-2-ilo o 2-oxo1,2-difenil-etilo;R2 es=O ohidrogeno; R3 es hidrogeno, isoindolil-1,3-diona, alcoxilo inferior, alquilo inferior, amino, benciloxilo, -CH2OR5 oCH2N(R5)2; R4 es hi drogeno o CH2OR5; R5 eshidrogeno o alquilo inferior, A es ciclohexilo o fenilo, opcionalmente sustituido con alquilo inferior, halogeno o alcoxilo, mezclas racémicas y suscorrespondientes enantiomeros y las sales de adicion deácido farmacéuticamente aceptables de los mismos; un procedimiento para su preparacion, medicamento quelos comprenden y el empleo de los mismos para la preparacion de un medicamento. Uso: trastornos psiquiátricos, neurologicos y fisiologicos.
ARP990102763A 1998-06-12 1999-06-10 Derivados diaza-espiro[3,5]nonano, un procedimiento para su preparacion, composiciones farmaceuticas que los comprenden y el uso de los mismos para la preparacion de un medicamento AR019859A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98110804 1998-06-12

Publications (1)

Publication Number Publication Date
AR019859A1 true AR019859A1 (es) 2002-03-20

Family

ID=8232114

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990102763A AR019859A1 (es) 1998-06-12 1999-06-10 Derivados diaza-espiro[3,5]nonano, un procedimiento para su preparacion, composiciones farmaceuticas que los comprenden y el uso de los mismos para la preparacion de un medicamento

Country Status (28)

Country Link
US (1) US6113527A (es)
EP (1) EP0970957B1 (es)
JP (1) JP3286268B2 (es)
KR (1) KR100344732B1 (es)
CN (1) CN1107066C (es)
AR (1) AR019859A1 (es)
AT (1) ATE204279T1 (es)
AU (1) AU743983B2 (es)
BR (1) BR9902651A (es)
CA (1) CA2274202A1 (es)
DE (1) DE69900220T2 (es)
DK (1) DK0970957T3 (es)
ES (1) ES2162503T3 (es)
HR (1) HRP990188A2 (es)
HU (1) HU220894B1 (es)
ID (1) ID23304A (es)
IL (1) IL130377A0 (es)
MA (1) MA26644A1 (es)
NO (1) NO312590B1 (es)
NZ (1) NZ336189A (es)
PE (1) PE20000548A1 (es)
PL (1) PL333695A1 (es)
PT (1) PT970957E (es)
SG (1) SG79259A1 (es)
SI (1) SI0970957T1 (es)
TR (1) TR199901381A3 (es)
YU (1) YU26499A (es)
ZA (1) ZA993852B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030040479A1 (en) * 2001-07-02 2003-02-27 Omeros Corporation Rotational intrathecal analgesia method and device
CA2490386A1 (en) * 2001-07-02 2003-01-16 Omeros Corporation Method for producing analgesia comprising administration of an opioid receptor agonist in rotation with an opioid receptor like-1 receptor agonist
US7566728B2 (en) 2002-03-29 2009-07-28 Mitsubishi Tanabe Pharma Corporation Remedy for sleep disturbance
JP2005289816A (ja) 2002-05-14 2005-10-20 Banyu Pharmaceut Co Ltd ベンズイミダゾール誘導体
JP4749715B2 (ja) 2002-07-05 2011-08-17 ターガセプト，インコーポレイテッド Ｎ−アリールジアザスピロ環式化合物、並びにその製造及び使用方法
WO2004022558A2 (en) * 2002-09-09 2004-03-18 Janssen Pharmaceutica, N.V. Hydroxy alkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of orl-1 receptor mediated disorders
GB0323204D0 (en) * 2003-10-03 2003-11-05 Novartis Ag Organic compounds
US20050228023A1 (en) * 2003-12-19 2005-10-13 Sri International Agonist and antagonist ligands of the nociceptin receptor
US20060178390A1 (en) * 2004-08-02 2006-08-10 Alfonzo Jordan 1,3,8-Triazaspiro[4,5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disorders
CN101022801A (zh) * 2004-08-20 2007-08-22 塔加西普特公司 N－芳基二氮杂螺环化合物在成瘾治疗中的用途
US20080247964A1 (en) * 2006-05-08 2008-10-09 Yuelian Xu Substituted azaspiro derivatives
WO2008067167A1 (en) * 2006-11-28 2008-06-05 Janssen Pharmaceutica N.V. Salts of 3-(3-amino-2-(r)-hydroxy-propyl)-1-(4-fluoro-phenyl)-8-(8-methyl-naphthalen-1-ylmethyl)-1,3,8-triaza-spiro[4.5]decan-4-one
CN101679430B (zh) * 2007-04-09 2013-12-25 詹森药业有限公司 用于治疗焦虑和抑郁症的作为orl-1受体的配体的1,3,8-三取代-1,3,8-三氮杂-螺[4.5]癸-4-酮衍生物
KR101704226B1 (ko) 2015-06-30 2017-02-07 현대자동차주식회사 자동차의 쿼터글라스 어셈블리
TW202340202A (zh) * 2021-12-22 2023-10-16 美國加利福尼亞大學董事會 Gtp酶抑制劑及其用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5756743A (en) * 1996-04-10 1998-05-26 Hoechst Marion Roussel Inc. Spiro cyclopent b!indole-piperidines!

Also Published As

Publication number Publication date
JP2000053679A (ja) 2000-02-22
ID23304A (id) 2000-04-05
EP0970957A1 (en) 2000-01-12
YU26499A (sh) 2002-09-19
IL130377A0 (en) 2000-06-01
AU3498799A (en) 1999-12-23
ES2162503T3 (es) 2001-12-16
NZ336189A (en) 2000-10-27
SI0970957T1 (es) 2001-12-31
TR199901381A2 (xx) 2000-01-21
SG79259A1 (en) 2001-03-20
CA2274202A1 (en) 1999-12-12
TR199901381A3 (tr) 2000-01-21
KR20000006060A (ko) 2000-01-25
ATE204279T1 (de) 2001-09-15
PT970957E (pt) 2002-02-28
BR9902651A (pt) 2000-05-16
DE69900220T2 (de) 2002-05-08
NO992873L (no) 1999-12-13
HRP990188A2 (en) 2000-02-29
NO312590B1 (no) 2002-06-03
KR100344732B1 (ko) 2002-07-19
ZA993852B (en) 1999-12-13
MA26644A1 (fr) 2004-12-20
DK0970957T3 (da) 2001-12-03
HU220894B1 (en) 2002-06-29
US6113527A (en) 2000-09-05
CN1242366A (zh) 2000-01-26
PE20000548A1 (es) 2000-07-15
DE69900220D1 (de) 2001-09-20
NO992873D0 (no) 1999-06-11
PL333695A1 (en) 1999-12-20
JP3286268B2 (ja) 2002-05-27
AU743983B2 (en) 2002-02-14
EP0970957B1 (en) 2001-08-16
HU9901911D0 (en) 1999-08-30
HUP9901911A1 (hu) 2000-05-28
CN1107066C (zh) 2003-04-30

Similar Documents

Publication Publication Date Title
AR019859A1 (es) Derivados diaza-espiro[3,5]nonano, un procedimiento para su preparacion, composiciones farmaceuticas que los comprenden y el uso de los mismos para la preparacion de un medicamento
SE0104334D0 (sv) Therapeutic agents
HUP0402336A2 (hu) Tieno[2,3-d]pirimidin-2,4-dion-származékok, eljárás előállításukra, alkalmazásuk autoimmun betegségek modulálására és a vegyületeket tartalmazó gyógyszerkészítmények
PA8472301A1 (es) Derivados de isotiazol utiles como agentes anticancerosos
MY118163A (en) Aryl fused azapolycyclic compounds
ZA932168B (en) Naphthylalkylamines, process for preparing them and pharmaceutical compositions containing them
AR006360A1 (es) Derivados de 1,2,3,4-tetrahidronaftaleno substituidos, uso de los mismos para la preparacion de medicamentos y procedimiento para su preparacion.
MX21088A (es) N-heteroanil-purin-6-aminas, y un proceso para su preparacion y su uso como medicamentos.
YU224790A (sh) Aminokarbonil karbamati, sorodni fizostigminu/in postopek za njihovo pripravo in njihova uporaba kot zdravila
AR019860A1 (es) Derivados di o triaza-espiro (4,5) decano, un procedimiento para su preparacion, un medicamento que los comprende y empleo de dichos derivados para la manufactura de un medicamento.
GEP20063759B (en) Novel Benzothiazine and Benzothiadiazine Derivatives, Method for Preparing Same and Pharmaceutical Compositions Containing Same
GB2291592B (en) Pharmaceutical compositions comprising a bicycloheptane derivative
AR020294A1 (es) COMPUESTOS DERIVADOS DE 1-TRIFLUOROMETIL-4-HIDROXI-7-PIPERIDINIL-AMINOMETILCROMANO, COMPOSICION FARMACEUTICA Y USO EN LA PREPARACIoN DE MEDICAMENTOS.
HU895648D0 (en) Process for the preparation of n,n-disubstituted diaryl-alkancarboxylic acid amide derivatives and pharmaceutical compositions containing such compounds
AR013538A1 (es) Nuevos mitogenos especificos de osteoblastos, metodos para prepararlos y drogas que contienen tales compuestos
HUP0003856A2 (hu) 6-Pirrolidin-2-ilpirindin-származékok, eljárás előállításukra és gyógyászati alkalmazásuk
CA2246482A1 (fr) Nouvelles trans-3,4,4a,5,6,10b-hexahydro-2h-napht [1,2-b]-1,4-oxazines disubstitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
ES2076054T3 (es) Nuevas amino-alquil-cromonas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
IT1313583B1 (it) Derivati 2-amminotetralinici per la terapia del glaucoma.
ECSP993008A (es) Derivados de diaza- espiro [3,5] nonano
GEP20063757B (en) Novel Benzothiazine and Benzothiadiazine Derivatives, Method for Preparing Same and Pharmaceutical Compositions Containing Same
HU9302081D0 (en) Procedure for producing preparations for preventing and/or curing ulceral diseases
ES2123038T3 (es) Nuevos derivados pirrolo-tieno-pirazinicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
UY28142A1 (es) Agentes terapéuticos
CA2238710A1 (en) New amino alcohol derivatives, processes for their production and pharmaceutical agents containing these compounds

Legal Events

Date Code Title Description
FG Grant, registration